Jaime Laurel Schneider MD PhD

Summary

• Dr. Jaime L. Schneider is a thoracic oncologist and physician–scientist based in Boston, MA. She earned her M.D./Ph.D. at Albert Einstein College of Medicine and completed her internal medicine residency at Massachusetts General Hospital and Medical Oncology fellowship training at Dana-Farber Cancer Institute. She is a medical oncologist in the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and her research program is in the Division of Molecular and Cellular Oncology at DFCI, where she is the principal investigator of a lab focused on targeted therapies and mechanisms of resistance in lung cancer. A major emphasis of her work is on oncogene-driven lung cancers, with broader efforts to define metabolic vulnerabilities and therapeutic strategies across oncogene-driven non–small cell lung cancer. Dr. Schneider has authored publications in Cell, Nature Cancer, NPJ Precision Oncology, The Oncologist, and JTO Clinical and Research Reports. Her work on ALK-positive lung cancer has been highly cited, reflecting her contributions to advancing precision oncology. As a lab-based physician–scientist, she integrates patient care with translational research to accelerate the development of novel therapies for patients with lung cancer.